Arthritis, Juvenile - 30 Studies Found
Completed |
: BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis : Juvenile Rheumatoid Arthritis : 2004-11-01 :
|
Completed |
: Study of Antibodies to Anti-TNF Agents in Juvenile Idiopathic Arthritis : Juvenile Idiopathic Arthritis : 2011-09-13 |
Completed |
: Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With Juvenile Rheumatoid Arthritis : Juvenile Rheumatoid Arthritis : 2008-06-02 : Biological: Adalimumab Adalimumab administered subcutaneously every other week, with dosage determined b |
Completed |
: Jointstrong Intervention for Juvenile Arthritis : Juvenile Arthritis : 2010-07-19 :
|
Recruiting |
: Oxidation Rates of the Different Substrates During Exercise in Children and Adolescents With Juvenile Idiopathic Arthritis. Case-control Study and Cases Treated / Cases Not Treated With Anti-TNFα : Juvenile Idiopathic Arthritis : 2016-11-28 : Other: anti-TNFα |
Completed |
: Effect of Whole Body Vibration Therapy in Children With Juvenile Idiopathic Arthritis : Juvenile Idiopathic Arthritis : 2009-02-03 : Device: Galileo (whole body vibration (WBV) therapy) 6 minutes of training on 5 days a week for 3 months |
Recruiting |
: Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis : Juvenile Idiopathic Arthritis : 2011-12-22 :
|
Completed |
: Juvenile Rheumatoid Arthritis Research Registry : Juvenile Rheumatoid Arthritis : 2004-08-27 |
Recruiting |
: Prediction of Temporomandibular Involvement in Juvenile Idiopathic Arthritis :
: 2014-06-30 |
RECRUITING |
: STep-up and Step-down Therapeutic Strategies in Childhood ARthritiS : Oligoarthritis, Juvenile : 2024-11-21 : Patients will receive etanercept subcutaneously at a dose of 0.8 mg/kg weekly (up to a maximum dose of 50 mg weekly). |